Filtered By:
Specialty: Pharmaceuticals
This page shows you your search results in order of date. This is page number 4.
Order by Relevance | Date
Total 890 results found since Jan 2013.
Disease Burden of Ischemic Stroke Predicted to Continue Increasing
FRIDAY, May 19, 2023 -- The disease burden of ischemic stroke increased from 1990 to 2019 and is predicted to continue increasing, according to a study published online May 17 in Neurology.
Jiahui Fan, from the Shanghai Fourth People ' s Hospital in...
Source: Drugs.com - Pharma News - May 19, 2023 Category: Pharmaceuticals Source Type: news
Stroke prevention and the future of stroke care
Stroke is the fifth leading cause of death in the United States. The Georgia Department of Public Health reports the state had the 12th highest stroke death rate in the country. Georgia is also part of the “stroke belt,” an area of the southeastern United States with stroke death rates 30% higher than the rest of the nation.
As the leading — but preventable — cause of disability, stroke can happen at any age.
Stroke is a medical emergency, meaning the blood flow to an area of the brain…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 19, 2023 Category: Pharmaceuticals Source Type: news
Roche ’s BTK inhibitor fenebrutinib significantly reduced brain lesions in people with relapsing forms of multiple sclerosis
Fenebrutinib is an investigational, potent and highly selective oralBruton ’s tyrosine kinase (BTK) inhibitor, the only reversible BTK inhibitor currently in Phase III multiple sclerosis (MS) trialsPhase II study met its primary and secondary endpoints by reducing the total number of new gadolinium-enhancing T1 brain lesions and significantly reducing the total number of new or enlarging T2 brain lesions compared to placeboThe safety profile offenebrutinib was consistent with previous and ongoing clinical trials across more than 2,400 people to dateBasel, 17 May 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today p...
Source: Roche Media News - May 17, 2023 Category: Pharmaceuticals Source Type: news
Bayer receives U.S. FDA Fast Track Designation for asundexian atrial fibrillation program
Bayer today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for its investigational drug asundexian (BAY2433334) as a potential treatment to prevent stroke and systemic embolism in people with atrial fibrillation (AF). This news follows asundexian's first U.S. FDA Fast Track Designation for the prevention of stroke in patients after a non-cardioembolic ischemic stroke, which was granted in 2022.
Source: World Pharma News - May 16, 2023 Category: Pharmaceuticals Tags: Featured Bayer Business and Industry Source Type: news
Statin Use Cuts Five-Year Stroke Risk for Patients With Atrial Fibrillation
MONDAY, May 15, 2023 -- Statin use is associated with a lower risk for incident stroke and transient ischemic attack (TIA) in a duration-dependent manner among patients with atrial fibrillation (AF), according to a study presented at the annual...
Source: Drugs.com - Pharma News - May 15, 2023 Category: Pharmaceuticals Source Type: news
Risk for MI, Ischemic Stroke Increased for Younger Adults With Mental Disorders
TUESDAY, May 9, 2023 -- Younger adults with mental disorders have an increased risk for myocardial infarction (MI) and ischemic stroke (IS), according to a study published online April 28 in the European Journal of Preventive Cardiology.
Chan Soon...
Source: Drugs.com - Pharma News - May 9, 2023 Category: Pharmaceuticals Source Type: news
Fetal Embolization Feasible for Vein of Galen Malformation
MONDAY, May 8, 2023 -- Transuterine ultrasound-guided fetal embolization of vein of Galen malformation is feasible and eliminates postnatal pathophysiology, according to a research letter published online May 4 in Stroke.
Darren B. Orbach, M.D.,...
Source: Drugs.com - Pharma News - May 8, 2023 Category: Pharmaceuticals Source Type: news
Poststroke Cognitive Impairment Common
MONDAY, May 8, 2023 -- Poststroke cognitive impairment (PSCI) is common, and up to one-third of individuals with stroke develop dementia within five years, according to a scientific statement published online May 1 in Stroke.
Nada El Husseini, M.D.,...
Source: Drugs.com - Pharma News - May 8, 2023 Category: Pharmaceuticals Source Type: news
Increasing Physical Activity After Stroke Tied to Good Functional Outcomes at Six Months
WEDNESDAY, May 3, 2023 -- Increased physical activity following a stroke is associated with functional recovery at six months, according to a study published online May 1 in JAMA Network Open.
Dongni Buvarp, M.D., Ph.D., from University of...
Source: Drugs.com - Pharma News - May 3, 2023 Category: Pharmaceuticals Source Type: news
Patients ’ views and experiences on the use and safety of directly acting oral anticoagulants: a qualitative study
ConclusionsThere is a need to develop and evaluate theory-based interventions to promote patient knowledge, understanding and shared decision-making to optimise DOACs use and improve their safety.
Source: Journal of Pharmaceutical Policy and Practice - May 1, 2023 Category: Pharmaceuticals Source Type: research
AAN: Stroke Prevalence Stable Overall From 1999 to 2018
TUESDAY, April 25, 2023 -- From 1999 to 2018, the prevalence of self-reported stroke overall and by racial and ethnic group and age group remained stable, while an increase was seen among men, according to a study published online April 24 in JAMA...
Source: Drugs.com - Pharma News - April 25, 2023 Category: Pharmaceuticals Source Type: news
Racial Disparities in Stroke Mortality Increased During Pandemic
MONDAY, April 24, 2023 -- The difference in age-adjusted stroke death rates (AASDRs) between Black and White adults was higher during the pandemic than during the prepandemic period, according to research published in the April 21 issue of the U.S....
Source: Drugs.com - Pharma News - April 24, 2023 Category: Pharmaceuticals Source Type: news
Spanish-Only Speakers Have Worse Neurologic Stroke Outcomes
THURSDAY, April 13, 2023 -- Spanish-only speaking Mexican Americans with ischemic stroke and intracerebral hemorrhage have worse neurologic outcomes than English speakers, according to a study published online April 12 in Neurology.
Alejandro...
Source: Drugs.com - Pharma News - April 13, 2023 Category: Pharmaceuticals Source Type: news
Reach Neuro Receives FDA Breakthrough Device Designation for Device to Restore Arm and Hand Movement to Chronic Stroke Patients
Reach Neuro's Avantis device delivers small electrical impulses to the spinal cord to help stroke survivors regain motion and independence
PITTSBURGH, April 10, 2023 -- (Healthcare Sales & Marketing Network) -- Reach Neuro, Inc., a neurotechnology comp... Devices, Neurology, FDA Reach Neuro, Avantis, stroke
Source: HSMN NewsFeed - April 10, 2023 Category: Pharmaceuticals Source Type: news
